Reassessing The Changing Outlook For Sangamo Therapeutics Inc (SGMO)
Currently, there are 208.62M common shares owned by the public and among those 199.09M shares have been available to trade. The company’s stock has a 5-day price change of 32.25% and 217.30% over the past three months. SGMO shares are trading 386.84% year to date (YTD), with the 12-month market performance up to 515.12% higher. […]
Gains May Be On The Menu For Sangamo Therapeutics Inc (NASDAQ: SGMO)
Currently, there are 208.62M common shares owned by the public and among those 199.07M shares have been available to trade. The company’s stock has a 5-day price change of -9.30% and 131.10% over the past three months. SGMO shares are trading 258.92% year to date (YTD), with the 12-month market performance up to 302.06% higher. […]
Sangamo Therapeutics Inc (NASDAQ: SGMO) Hogging The Spotlight Today
Currently, there are 208.62M common shares owned by the public and among those 199.07M shares have been available to trade. The company’s stock has a 5-day price change of 10.82% and 169.36% over the past three months. SGMO shares are trading 295.73% year to date (YTD), with the 12-month market performance up to 373.46% higher. […]
Sangamo Therapeutics Inc (SGMO): Street Finally Waking Up
Currently, there are 208.65M common shares owned by the public and among those 199.04M shares have been available to trade. The company’s stock has a 5-day price change of 9.18% and 170.89% over the past three months. SGMO shares are trading 293.89% year to date (YTD), with the 12-month market performance up to 472.96% higher. […]
Do Sangamo Therapeutics Inc (NASDAQ: SGMO) Fit In A Value Investing Philosophy?
Currently, there are 208.65M common shares owned by the public and among those 199.04M shares have been available to trade. The company’s stock has a 5-day price change of -29.63% and 133.07% over the past three months. SGMO shares are trading 249.71% year to date (YTD), with the 12-month market performance up to 441.77% higher. […]
Sangamo Therapeutics Inc (NASDAQ: SGMO) Loses -3.37% From High. Why That Could Change?
Currently, there are 208.22M common shares owned by the public and among those 198.63M shares have been available to trade. The company’s stock has a 5-day price change of 52.66% and 160.91% over the past three months. SGMO shares are trading 428.25% year to date (YTD), with the 12-month market performance up to 655.26% higher. […]
Reviewing The Case For Sangamo Therapeutics Inc (SGMO) Going Higher
Currently, there are 208.22M common shares owned by the public and among those 198.63M shares have been available to trade. The company’s stock has a 5-day price change of -14.71% and 75.72% over the past three months. SGMO shares are trading 220.27% year to date (YTD), with the 12-month market performance up to 278.26% higher. […]
Do Sangamo Therapeutics Inc (NASDAQ: SGMO) Fit In A Value Investing Philosophy?
Currently, there are 208.22M common shares owned by the public and among those 198.84M shares have been available to trade. The company’s stock has a 5-day price change of 62.92% and 63.63% over the past three months. SGMO shares are trading 176.09% year to date (YTD), with the 12-month market performance up to 212.50% higher. […]
Sangamo Therapeutics Inc (SGMO) Volatility Spurs A Quest For Clarity
Currently, there are 208.22M common shares owned by the public and among those 198.84M shares have been available to trade. The company’s stock has a 5-day price change of 24.60% and 116.07% over the past three months. SGMO shares are trading 122.71% year to date (YTD), with the 12-month market performance up to 134.77% higher. […]
Value Hunters: Look To Sangamo Therapeutics Inc (SGMO)
Currently, there are 208.22M common shares owned by the public and among those 198.84M shares have been available to trade. The company’s stock has a 5-day price change of 15.58% and 101.74% over the past three months. SGMO shares are trading 70.66% year to date (YTD), with the 12-month market performance up to 87.31% higher. […]
